From Bioblast
Description
Aspirin is a widely applied drug that requires dosage adjusted to individual body mass. It is a non-selective COX inhibitor and exerts an effect on long-chain fatty acid transport into mitochondria.
Reference: Uppala 2017 Biochem Biophys Res Commun
Aspirin and mitObesity
Work in progress by Gnaiger E 2023-09-24 linked to a preprint in preparation on mitObesity drugs - mitObesity.
References: Aspirin
Year | Reference | Organism | Tissue;cell | Pathology | |
---|---|---|---|---|---|
Chen 2023 Front Oncol | 2023 | Chen L, Zhu C, Pan F, Chen Y, Xiong L, Li Y, Chu X, Huang G (2023) Platelets in the tumor microenvironment and their biological effects on cancer hallmarks. Front Oncol 13:1121401. https://doi.org/10.3389/fonc.2023.1121401 | Human | Blood cells Platelet | Cancer |
Ravera 2023 Cells | 2023 | Ravera S, Signorello MG, Panfoli I (2023) Platelet metabolic flexibility: a matter of substrate and location. Cells 12:1802. https://doi.org/10.3390/cells12131802 | Human | Blood cells Platelet | Cancer Cardiovascular Diabetes Obesity |
Bian 2022 Heliyon | 2022 | Bian X, Yin S, Yang S, Jiang X, Wang J, Zhang M, Zhang L (2022) Roles of platelets in tumor invasion and metastasis: a review. Heliyon 8:e12072. https://doi.org/10.1016/j.heliyon.2022.e12072 | Human | Blood cells Platelet | Cancer |
Tao 2021 Blood | 2021 | Tao DL, Tassi Yunga S, Williams CD, McCarty OJT (2021) Aspirin and antiplatelet treatments in cancer. Blood 137:3201-11. https://doi.org/10.1182/blood.2019003977 | Human | Blood cells Platelet | Cancer |
John 2021 Life (Basel) | 2021 | John A, Amiri L, Shafarin J, Howarth FC, Raza H (2021) Effect of aspirin on mitochondrial dysfunction and stress in the pancreas and heart of Goto-Kakizaki diabetic rats. Life (Basel) 11:902. https://doi.org/10.3390/life11090902 | Rat | Heart Islet cell;pancreas;thymus | Diabetes |
Lichtenberger 2019 Cancer Res | 2019 | Lichtenberger LM, Vijayan KV (2019) Are platelets the primary target of aspirin's remarkable anticancer activity? Cancer Res 79:3820-3. https://doi.org/10.1158/0008-5472.CAN-19-0762 | Human | Platelet | Cancer |
Farrugia 2019 Sci Rep | 2019 | Farrugia G, Azzopardi M, Saliba C, Grech G, Gross AS, Pistolic J, Benes V, Vassallo N, Borg J, Madeo F, Eisenberg T, Balzan R (2019) Aspirin impairs acetyl-coenzyme A metabolism in redox-compromised yeast cells. Sci Rep 9:6152. https://doi.org/10.1038/s41598-019-39489-4 | Saccharomyces cerevisiae | Cancer | |
Sowton 2018 Biochem Biophys Res Commun | 2018 | Sowton AP, Millington-Burgess SL, Murray AJ, Harper MT (2018) Rapid kinetics of changes in oxygen consumption rate in thrombin-stimulated platelets measured by high-resolution respirometry. Biochem Biophys Res Commun 503:2721-27. | Human | Platelet Blood cells | |
Uppala 2017 Biochem Biophys Res Commun | 2017 | Uppala R, Dudiak B, Beck ME, Bharathi SS, Zhang Y, Stolz DB, Goetzman ES (2017) Aspirin increases mitochondrial fatty acid oxidation. Biochem Biophys Res Commun 482:346-51. | Human Mouse | HEK Fibroblast | Other |
Ornelas 2017 Cancer Metastasis Rev | 2017 | Ornelas A, Zacharias-Millward N, Menter DG, Davis JS, Lichtenberger L, Hawke D, Hawk E, Vilar E, Bhattacharya P, Millward S (2017) Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention. Cancer Metastasis Rev 36:289-303. https://doi.org/10.1007/s10555-017-9675-z | Human | Blood cells Platelet | Cancer |
Kassassir 2016 Chem Biol Interact | 2016 | Kassassir H, Siewiera K, Talar M, Stec-Martyna E, Pawlowska Z, Watala C (2016) Non-enzymatic modifications of prostaglandin H synthase 1 affect bifunctional enzyme activity - Implications for the sensitivity of blood platelets to acetylsalicylic acid. Chem Biol Interact 253:78-92. | Other mammals | Diabetes | |
Alfonso 2014 Br J Cancer | 2014 | Alfonso L, Ai G, Spitale RC, Bhat GJ (2014) Molecular targets of aspirin and cancer prevention. Br J Cancer 111:61-7. https://doi.org/10.1038/bjc.2014.271 | Human | Blood cells Platelet | Cancer |
Gottfried 2013 PLoS One | 2013 | Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A, Mackensen A, Grauer O, Hau P, Dettmer K, Andreesen R, Oefner PJ, Kreutz M (2013) New aspects of an old drug - Diclofenac targets MYC and glucose metabolism in tumor cells. PLoS One 8:e66987. | Human Mouse | Endothelial;epithelial;mesothelial cell Blood cells Other cell lines Lymphocyte | Cancer |
Santilli 2012 Obes Rev | 2012 | Santilli F, Vazzana N, Liani R, Guagnano MT, Davì G (2012) Platelet activation in obesity and metabolic syndrome. Obes Rev 13:27-42. https://doi.org/10.1111/j.1467-789X.2011.00930.x | Human | Blood cells Platelet | Diabetes Obesity |
MitoPedia: mitObesity drugs
Healthy reference population | Body mass excess | BFE | BME cutoffs | BMI | H | M | VO2max | mitObesity drugs |
MitoPedia concepts:
MiP concept
Labels:
MitoPedia:mitObesity drug